Tokyo, Aug. 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058661) titled 'Fukuoka Red Cross hospital Peritoneal Dialysis Registry' on Aug. 1.
Study Type:
Observational
Primary Sponsor:
Institute - kentaro-kyu@umin.org
Condition:
Condition - End-stage kidney disease on peritoneal dialysis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To develop evidence related to peritoneal dialysis, including mortality and cardiovascular events, withdrawal from peritoneal dialysis, and development of infections including peritonitis and exit-site infections.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - All patients receiving peritoneal dialysis therapy at our hospital or who were receiving peritoneal dialysis therapy on or after April 1, 2018 will be included.
Key exclusion criteria - (i) Cases who requested not to participate in this study based on publicly available information
(ii) Untraceable cases
Target Size - 300
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 07 Month 25 Day
Date of IRB - 2025 Year 07 Month 24 Day
Anticipated trial start date - 2025 Year 07 Month 25 Day
Last follow-up date - 2035 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067081
Disclaimer: Curated by HT Syndication.
